Patents Assigned to RAJIV GANDHI CENTRE FOR BIOTECHNOLOGY, AN AUTONOMOUS INSTITUTE UNDER THE DEPARTMENT OF BIOTECHNOLOGY. GOVERNMENT OF INDIA
  • Uttroside B and derivatives thereof as therapeutics for hepatocellular carcinoma
    Patent number: 11738036
    Abstract: The present invention includes Uttroside B compositions and method for the treatment of hepatocellular carcinoma. Chemotherapeutic options for liver cancer are limited and the prognosis of HCC patients remains dismal. Sorafenib, is the only drug currently available for the treatment of hepatocellular carcinoma.
    Type: Grant
    Filed: May 27, 2017
    Date of Patent: August 29, 2023
    Assignee: RAJIV GANDHI CENTRE FOR BIOTECHNOLOGY, AN AUTONOMOUS INSTITUTE UNDER THE DEPARTMENT OF BIOTECHNOLOGY, GOVERNMENT OF INDIA
    Inventors: Ruby John Anto, Lekshmi Reghu Nath
  • Uttroside B and derivatives thereof as therapeutics for hepatocellular carcinoma
    Patent number: 11607422
    Abstract: The present invention includes Uttroside B compositions and method for the treatment of hepatocellular carcinoma. Chemotherapeutic options for liver cancer are limited and the prognosis of HCC patients remains dismal. Sorafenib, is the only drug currently available for the treatment of hepatocellular carcinoma.
    Type: Grant
    Filed: January 29, 2021
    Date of Patent: March 21, 2023
    Assignee: RAJIV GANDHI CENTRE FOR BIOTECHNOLOGY, AN AUTONOMOUS INSTITUTE UNDER THE DEPARTMENT OF BIOTECHNOLOGY. GOVERNMENT OF INDIA
    Inventors: Ruby John Anto, Lekshmi Reghu Nath